Newsbot

South Africa’s Ramaphosa Cancels Trip as DA Mulls GNU Role

South African President Cyril Ramaphosa canceled an international trip at the last minute ahead of an announcement by the second-biggest party in his coalition government after it gave him a 48-hour ultimatum, according to people familiar with the matter.

Esken ruft SPD zu Kampf gegen "Menschenfeinde" auf

Berlin - Ex-SPD-Chefin Saskia Esken hat ihre Partei zu einem weiteren Kampf gegen Rechtsextremismus aufgefordert."Noch bitterer" als das schwache Abschneiden bei der Bundestagswahl sei "die Breitbe...

Are These Volatile AI Stocks Worth Buying Now?

The growing adoption of artificial intelligence is driving tremendous growth for the semiconductor industry. But demand for chips can be cyclical, which can lead to volatility for many of these stocks. Its important to understand that wild swings in share prices dont tell you anything about the long-term direction of the business. Volatility can be a long-term investors friend, providing the opportunity to buy competitively positioned companies at attractive valuations.Where to invest $1,000 ...

Could Buying AST SpaceMobile Stock Today Set You Up for Life?

AST SpaceMobile (NASDAQ: ASTS) is an exciting stock. It has such an interesting story backing it that some investors might wonder if buying in now could help to set them up for life. That is possible, but theres one small problem that you need to consider before stepping in here. This is what you need to know about AST SpaceMobile before you buy it. What does AST SpaceMobile do? AST SpaceMobile operates a satellite-based broadband cellular network. It is really just starting to build out that n...

Got $500? 2 Healthcare Stocks to Buy and Hold Forever

I dont know if well be riding in personal aircraft 20 years from now, like George Jetson did in the cartoon TV series. I dont know if artificial intelligence (AI) will replace millions of jobs. But theres one thing Im quite confident about: Well still need healthcare products and services in the future, whether were talking about 10 or 100 years from now. The healthcare sector is an ideal place for long-term investors to focus their attention, in my view. The trick is to find the stocks o...

Small-cap movers: End of the ice age for AIM?

After more than three years of deep freeze, liquidity dried up, valuations languished, and investor apathy reigned, there are signs of a tentative spring....

3 Green Flags for Dogecoin in the Next 12 Months

Dogecoin (CRYPTO: DOGE) remains a fundamentals-free asset, yet its price keeps reviving whenever the macroeconomic tides shift. Ignoring the patterns that drive its price risks missing what the next 12 months could look like for crypto, including for majors like Bitcoin (CRYPTO: BTC). Investors need not buy Dogecoin to learn its lessons. The token behaves like a seismograph for macro liquidity and market sentiment about crypto, and three macro currents in particular line up in its favor right no...

Novo Nordisk (NVO) Terminates Hims & Hers Partnership Over Wegovy Sales Issues

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued its partnership with Hims & Hers concerning selling its weight-loss drug, Wegovy. This decision was made less than two months after the companies had initially announced their collaboration. According to Novo […]

Aktie eskaliert: Heidelberg Materials mit Mega-Kaufsignal

Die Aktie des Baustoffkonzerns Heidelberg Materials gehört bereits seit Jahresbeginn zu den prägenden Titeln im Dax. Im Mai kam die furiose Rally jedoch ins Stocken. Es entwickelte sich eine Konsol...

Is Palantir a Millionaire-Maker Stock?

Palantir (NASDAQ: PLTR) has already delivered solid returns to patient investors. If you invested $10,000 in the stock at the start of 2024, that investment is already worth $83,000. Thats not a bad return for just a year and a half. But many investors are wondering whether there is room for upside. After all, Palantir has had quite the run over the past few months. To continue turning that initial $10,000 investment into $1 million, Palantirs stock would need to rise by about 1,100% from toda...

The 5 Best Stocks to Buy With $5,000

As we approach the halfway point in the year, investors must look at their portfolios and see if theyve got some cash to deploy. While having a cash stockpile ready to use at a moments notice is a great safety net, too much cash can inhibit long-term returns. Furthermore, its nearly impossible to tell what the market will do following a huge news headline -- for example, the market has had a strong week despite the events in Iran last weekend. Investors with some cash to deploy should conside...

This 1 Cryptocurrency Could Soar 20,000% Over the Next 21 Years, According to Michael Saylor of Strategy (MicroStrategy)

On June 21, billionaire Michael Saylor, founder and executive chairman of Strategy (NASDAQ: MSTR) unveiled his latest price prediction for Bitcoin (CRYPTO: BTC): $21 million per coin. Thats significantly higher than most mainstream Bitcoin predictions, which usually top out at around $1 million. A price of $21 million would require Bitcoin to soar in value by nearly 20,000%. It would be easy to dismiss this prediction as just a pie-in-the-sky fantasy, except for one important fact: Bitcoin is u...

Microsoft - unsere Strategie geht auf

?? Stark investieren - in starke Marken. Du glaubst an Coca-Cola, Apple, Nike & Co.? Wir auch - und wir handeln danach. In dieser Woche konnten wir mit Nike den nächsten Treffer landen via Call WKN...

The Best Vanguard ETF to Invest $1,000 in Right Now

The financial services sector broadly, and the asset management industry specifically, are certainly major parts of the economy. Yet even in that space, some players stand out. For instance, Vanguard, which has been around for 50 years, is a huge entity that has more than $10 trillion in assets under management. The investment firms founder, Jack Bogle, pioneered passive investing, an innovation that has helped average retail investors immensely. Today, Vanguard has 441 different investment veh...

Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?

Investors looking for stocks that can produce dramatic gains in a short amount of time will want to turn their heads toward the biopharmaceutical space. Chasing short-term gains isnt the smartest way to invest, but hardly a month goes by without at least one stock from this industry shooting through the roof as the drugs it develops cross important milestones. The average Wall Street analyst following Editas Medicine (NASDAQ: EDIT) thinks the gene therapy stock can reach $3.25 per share in the ...

Amid War With Israel, Iran Pursues Enemies From Within

Iranian authorities are sweeping up hundreds of people deemed suspected spies or infiltrators. Some worry the campaign could become a broader crackdown on political opponents and minorities.